Conference Call to be Held Today at 4:30 p.m. ETSAN DIEGO, June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal year ended March 31, 2024 and provided an update on recent developments. Company UpdatesAethlon Medical is continuing the research and clinical development of its Hemopurifier®, a therapeutic blood filtration system de ...